bisoxatin acetate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
382 14008-48-1

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • bisoxatin acetate
  • exodol
  • lasotin
  • laxonalin
  • Molecular weight: 417.42
  • Formula: C24H19NO6
  • CLOGP: 2.80
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 1
  • TPSA: 90.93
  • ALOGS: -5.50
  • ROTB: 6

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 3.466 Moderate 0.66
caco2-efflux Caco-2 efflux ratio (BA/AB) 3.999 Moderate 0.66
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 22.699 10^-6 cm/s Moderate 0.66
dh-clint Dog hepatocyte intrinsic clearance 156.675 uL/min/10^6 cells Moderate 0.66
dppb Dog plasma protein binding (% unbound) 1.070 % Moderate 0.66
fcs-ppb Fetal calf serum protein binding (% unbound) 1.720 % Moderate 0.66
herg hERG pIC50 5.039 pIC50 Moderate 0.66
hh-clint Human hepatocyte intrinsic clearance 407.380 uL/min/10^6 cells Moderate 0.66
hlm-clint Human liver microsomal intrinsic clearance 286.418 uL/min/mg protein Moderate 0.66
hppb Human plasma protein binding (% unbound) 0.790 % Moderate 0.66
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 7.551 Moderate 0.66
mh-clint Mouse hepatocyte intrinsic clearance 322.107 Moderate 0.66
mppb Mouse plasma protein binding (% unbound) 1.270 Moderate 0.66
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 19.364 Moderate 0.66
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 2.750 % Moderate 0.66
rh-clint Rat hepatocyte intrinsic clearance 293.089 uL/min/10^6 cells Moderate 0.66
rh-fuinc Rat hepatocyte fraction unbound in incubation 21.630 % Moderate 0.66
rppb Rat plasma protein binding (% unbound) 0.760 % Moderate 0.66
solubility-dd Solubility at pH 7.4 in DMSO 4.064 uM Moderate 0.66

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
CHEBI has role CHEBI:50503 laxative

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.99 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01191 KEGG_DRUG
C0613290 UMLSCUI
CHEBI:31294 CHEBI
CHEMBL2106004 ChEMBL_ID
DB14654 DRUGBANK_ID
C030065 MESH_SUPPLEMENTAL_RECORD_UI
26391 PUBCHEM_CID
79W5LFS83K UNII
C3652923 UMLSCUI
DB09219 DRUGBANK_ID
28689 PUBCHEM_CID
2348 INN_ID

Pharmaceutical products:

None